- Home
- CUE vs MAMK Comparison
CUE vs MAMK Comparison
Compare CUE & MAMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- MAMK
- Stock Information
- Founded
- CUE 2014
- MAMK 2007
- Country
- CUE United States
- MAMK China
- Employees
- CUE N/A
- MAMK N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- MAMK Apparel
- Sector
- CUE Health Care
- MAMK Consumer Discretionary
- Exchange
- CUE Nasdaq
- MAMK Nasdaq
- Market Cap
- CUE 61.1M
- MAMK 52.9M
- IPO Year
- CUE 2018
- MAMK 2025
- Fundamental
- Price
- CUE $0.70
- MAMK $4.21
- Analyst Decision
- CUE Strong Buy
- MAMK
- Analyst Count
- CUE 2
- MAMK 0
- Target Price
- CUE $3.00
- MAMK N/A
- AVG Volume (30 Days)
- CUE 270.3K
- MAMK 885.8K
- Earning Date
- CUE 11-12-2025
- MAMK 02-18-2026
- Dividend Yield
- CUE N/A
- MAMK N/A
- EPS Growth
- CUE N/A
- MAMK N/A
- EPS
- CUE N/A
- MAMK 0.12
- Revenue
- CUE $8,286,000.00
- MAMK $21,434,100.00
- Revenue This Year
- CUE N/A
- MAMK N/A
- Revenue Next Year
- CUE N/A
- MAMK N/A
- P/E Ratio
- CUE N/A
- MAMK $34.83
- Revenue Growth
- CUE N/A
- MAMK N/A
- 52 Week Low
- CUE $0.54
- MAMK $1.87
- 52 Week High
- CUE $1.99
- MAMK $12.78
- Technical
- Relative Strength Index (RSI)
- CUE 38.97
- MAMK N/A
- Support Level
- CUE $0.76
- MAMK N/A
- Resistance Level
- CUE $0.81
- MAMK N/A
- Average True Range (ATR)
- CUE 0.05
- MAMK 0.00
- MACD
- CUE -0.01
- MAMK 0.00
- Stochastic Oscillator
- CUE 10.92
- MAMK 0.00
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About MAMK MaxsMaking Inc. Class A Ordinary Shares
MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.